青蒿琥酯和熊果酸降血脂作用的最佳配比筛选

叶亚琳; 王玉亮; 王泽剑; 殷明; 辛海量; 张磊

doi:10.3969/j.issn.1006-0111.2014.03.008

青蒿琥酯和熊果酸降血脂作用的最佳配比筛选

doi: 10.3969/j.issn.1006-0111.2014.03.008

1.
解放军421医院药剂科, 广东广州 510310
2.
上海交通大学农业与生物学院, 上海 200240;上海交通大学药学院, 上海 200240
3.
上海交通大学药学院, 上海 200240
4.
第二军医大学中医系, 上海 200433
5.
第二军医大学药学院, 上海 200433

基金项目: 上海市科委中药现代化专项(10DZ1971500).

Screening the best ratio of artesunate and ursolic acid for lipid-lowering

1.
NO.421 Hospital of PLA, Guangzhou 510310, China
2.
School of Agriculture and Biology, Shanghai Jiaotong University, Shanghai 200240, China;School of Pharmacy, Shanghai Jiaotong University, Shanghai 200240, China
3.
School of Pharmacy, Shanghai Jiaotong University, Shanghai 200240, China
4.
School of Traditional;Chinese Medicine, Second Military Medical University, Shanghai 200433, China
5.
School of Pharmacy, Second Military Medical University, Shanghai 200433, China

摘要: 目的观察青蒿琥酯和熊果酸不同剂量和配伍对大鼠脂质代谢紊乱模型的影响,寻找青蒿琥酯和熊果酸配伍应用的最佳配比。方法利用喂养高脂饲料诱导大鼠形成脂质代谢紊乱模型,通过比较各给药组大鼠的血脂水平筛选最佳配比。结果实验结果显示,青蒿琥酯(高剂量)+熊果酸(高剂量)均有显著降低TG、CHO、LDL-C作用,可明显升高HDL-C,对H/L值也有一定的升高作用。综合降脂效果优于阳性药非诺贝特,也优于单用同等剂量的青蒿琥酯或熊果酸。各受试样品对大鼠肝功能没有显著影响(P>0.05,与正常组比较)。结论青蒿琥酯和熊果酸1:1配比降脂效果最佳,建议剂量为(50+50) mg/kg。
- 青蒿琥酯 /
- 熊果酸 /
- 高血脂 /
- 大鼠 /
- 脂代谢
Abstract: Objective To observe the effect of different doses unilateral and compound of artesunate and ursolic acid on lipid metabolism in rats' model, find out the best ratio of artesunate and ursolic acid. Methods Lipid metabolism disorders model was induced by feeding high fat diet in rat.The best ratio was screened through comparing the lipid level of rats ofdifferent groups. Results The results showed that Artesunate (high dose)+Ursolicacid (high dose) significantly reduced TG, CHO and LDL-C, increased HDL-C and H/L. Lipid-lowering effect was superior the positive drug fenofibrate, but also superior to the same dose of artesunate and ursolic acid alone. No significant effect of each test sample on the rat liver function was observed(P>0.05). Conclusion Artesunate and ursolic acid ratio of 1:1 had the best lipid-lowering effect, and the recommended dose was (50+50) mg/kg.
- artesunate /
- ursolic acid /
- hyperlipidemia /
- rat /
- lipid metabolism

[1]	Xu H, He Y, Yang X, et al. Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes[J]. Rheumatology,2007,46 (6):920-926.
[2]	Wang JX, Tang W, Zhou R, et al.The new water-soluble artemisinin derivative SM905 ameliorates collagen-induced arthritis by suppression of inflammatory and Th17 responses[J]. Br J Pharmacol, 2008, 153(6): 1303-1310.
[3]	Li WD, Dong YJ, Tu YY, et al.Dihydroarteannuin ameliorates lupus symptom of BXSB mice by inhibiting production of TNF-alpha and blocking the signaling pathway NF-kappa B translocation[J]. Int Immunopharmacol,2006,6 (8): 1243-1250.
[4]	Li B, Zhang R, Li J, et al. Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation[J]. Int Immunopharmacol, 2008, 8(3): 379-389.
[5]	Li T,Chen H,Wei N,et al. Anti-inflammatory and immunomodulatory mechanisms of artemisinin on contact hypersensitivity[J]. Int Immunopharmacol, 2012, 12(1):144-150.
[6]	Hou LF, He SJ, Li X, et al. Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses[J]. Arthritis Rheum, 2011, 63(8): 2445-2455.
[7]	Cheng C, Ho WE, Goh FY, et al. Anti-malarial drug artesunate attenuates experimental allergic asthma via inhibition of the phosphoinositide 3-kinase/Akt pathway[J]. PLoS One, 2011, 6(6): e20932.
[8]	Li Y, Wu YL. An over four millennium story behind qinghaosu (artemisinin)-a fantastic antimalarial drug from a traditional Chinese herb[J]. Curr Med Chem, 2003, 10 (21):2197-2223.
[9]	Jayaprakasam B, Olson LK, Schutzki RE, et al. Amelioration of obesity and glucose intolerance in high-fat-fed C57BL/6 mice by anthocyanins and ursolic acid in Cornelian cherry (Cornus mas)[J]. J Agric Food Chem,2006,54(1):243-248.
[10]	Somova LO, Nadar A, Rammanan P, et al. Cardiovascular, antihyperlipidemic and antioxidant effects of oleanolic and ursolic acids in experimental hypertension[J]. Phytomedicine,2003,10(2-3), 115-121.
[11]	Ullevig SL, Zhao Q, Zamora D, et al. Ursolic acid protects diabetic mice against monocyte dysfunction and accelerated atherosclerosis[J]. Atherosclerosis,2011,219 (2), 409-416.
[12]	唐克轩,王玉亮,辛海量.降血脂的中药组合物及其制备方法[P]. 中国专利,CN101507727,2009-08-19.

[1]	郭灵怡, 刘艳超, 高路, 刘瑞瑶, 吕权真, 俞媛. 醋酸卡泊芬净单硬脂酸甘油酯纳米粒抗白色念珠菌感染的增效作用研究 . 药学实践与服务, 2025, 43(3): 136-142, 150. doi: 10.12206/j.issn.2097-2024.202310043
[2]	晁亮, 王辉, 沈淑琦, 游飘雪, 冀凯宏, 洪战英. 基于UHPLC-Q/TOF-MS代谢组学策略的葛根-知母药对防治阿尔茨海默病的药效与作用机制研究 . 药学实践与服务, 2025, 43(1): 30-40. doi: 10.12206/j.issn.2097-2024.202409035
[3]	崔亚玲, 吴琼, 马良煜, 胡北, 姚东, 许子华. 肝素钠肌醇烟酸酯乳膏中肌醇烟酸酯皮肤药动学研究 . 药学实践与服务, 2025, 43(1): 6-9, 21. doi: 10.12206/j.issn.2097-2024.202404006
[4]	张俊丽, 李媛媛, 尹静, 杨鸿源, 白耀武. 咪达唑仑调节PINK1/PARKIN信号通路对缺血性脑卒中大鼠神经元损伤的影响 . 药学实践与服务, 2025, 43(6): 288-292, 312. doi: 10.12206/j.issn.2097-2024.202405024
[5]	竺东杰, 贺新征, 邹杰, 余史丹, 李红霞. 雷公藤甲素对大鼠脑缺血再灌注损伤的影响及机制研究 . 药学实践与服务, 2025, 43(7): 339-343, 361. doi: 10.12206/j.issn.2097-2024.202311021
[6]	冯一帆, 严啸东, 张文彬, 李炳锋, 郭美丽. 菸花苷长期给药对脑缺血再灌注损伤大鼠神经功能的影响 . 药学实践与服务, 2025, 43(5): 228-234. doi: 10.12206/j.issn.2097-2024.202407038
[7]	徐尧, 马春辉, 李志勇. 高血压对大鼠心血管纤维化及sFRP2表达的影响 . 药学实践与服务, 2025, 43(4): 180-184. doi: 10.12206/j.issn.2097-2024.202409055
[8]	魏雨辰, 田家盛, 王道鑫, 凌期盛, 王治, 缪朝玉. 烟酰胺单核苷酸口服给药对高血压大鼠的影响 . 药学实践与服务, 2025, 43(5): 213-221. doi: 10.12206/j.issn.2097-2024.202412006
[9]	肖树文, 周鹤洋, 金永生, 乔丽名, 郑巍. 齐墩果酸和熊果酸衍生物的化学合成及体外抗丙肝病毒作用的研究 . 药学实践与服务, 2025, 43(10): 503-508. doi: 10.12206/j.issn.2097-2024.202502045
[10]	何琳, 成彦琼, 叶侃倜, 赵娟娟, 陆蕙兰, 杨骏, 陈方剑. 血通胶囊降血脂以及肝脏保护作用研究 . 药学实践与服务, 2025, 43(): 1-7. doi: 10.12206/j.issn.2097-2024.202502015
[11]	陈炳辰, 佟达丰, 万苗, 闫飞虎, 姚建忠. UPLC-MS/MS法测定小鼠血浆中紫杉醇脂肪酸酯前药及其药代动力学研究 . 药学实践与服务, 2024, 42(8): 341-345. doi: 10.12206/j.issn.2097-2024.202404082
[12]	陈炳辰, 王思真, 郭贝贝, 杨峰. 紫杉醇棕榈酸酯的合成及其脂质体的制备与处方研究 . 药学实践与服务, 2024, 42(9): 379-384, 410. doi: 10.12206/j.issn.2097-2024.202404062
[13]	杨嘉宁, 赵一颖, 肖伟. 七味脂肝方对非酒精性脂肪性肝炎动物模型的药效学评价 . 药学实践与服务, 2024, 42(9): 389-398. doi: 10.12206/j.issn.2097-2024.202404096
[14]	孙丹倪, 黄勇, 张嘉宝, 王培. 代谢相关脂肪性肝病的无创诊断与药物治疗 . 药学实践与服务, 2024, 42(10): 411-418. doi: 10.12206/j.issn.2097-2024.202403049
[15]	赖立勇, 夏天爽, 徐圣焱, 蒋益萍, 岳小强, 辛海量. 中药青蒿抗氧化活性的谱效关系研究 . 药学实践与服务, 2024, 42(5): 203-210, 216. doi: 10.12206/j.issn.2097-2024.202211012
[16]	张修平, 田家盛, 王道鑫, 李佳鑫, 王品, 缪朝玉. MT-1207对小鼠血糖、血脂和动脉粥样硬化的作用 . 药学实践与服务, 2024, 42(11): 487-494. doi: 10.12206/j.issn.2097-2024.202306011
[17]	毛智毅, 王筱燕, 陈晓颖, 汤逸斐. 度拉糖肽联合二甲双胍对肥胖型2型糖尿病患者机体代谢、体脂成分及血清脂肪因子的影响 . 药学实践与服务, 2024, 42(7): 305-309. doi: 10.12206/j.issn.2097-2024.202305032

点击查看大图

计量

文章访问数: 4445
HTML全文浏览量: 499
PDF下载量: 75
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

青蒿琥酯和熊果酸降血脂作用的最佳配比筛选

doi: 10.3969/j.issn.1006-0111.2014.03.008

Screening the best ratio of artesunate and ursolic acid for lipid-lowering

计量

青蒿琥酯和熊果酸降血脂作用的最佳配比筛选

doi: 10.3969/j.issn.1006-0111.2014.03.008

1. 解放军421医院药剂科, 广东广州 510310

2. 上海交通大学农业与生物学院, 上海 200240;上海交通大学药学院, 上海 200240

3. 上海交通大学药学院, 上海 200240

4. 第二军医大学中医系, 上海 200433

5. 第二军医大学药学院, 上海 200433

English Abstract

Screening the best ratio of artesunate and ursolic acid for lipid-lowering

全文HTML

目录

留言板

青蒿琥酯和熊果酸降血脂作用的最佳配比筛选

doi: 10.3969/j.issn.1006-0111.2014.03.008

Screening the best ratio of artesunate and ursolic acid for lipid-lowering

计量

出版历程

青蒿琥酯和熊果酸降血脂作用的最佳配比筛选

doi: 10.3969/j.issn.1006-0111.2014.03.008

1. 解放军421医院药剂科, 广东 广州 510310 2. 上海交通大学农业与生物学院, 上海 200240;上海交通大学药学院, 上海 200240 3. 上海交通大学药学院, 上海 200240 4. 第二军医大学中医系, 上海 200433 5. 第二军医大学药学院, 上海 200433

English Abstract

Screening the best ratio of artesunate and ursolic acid for lipid-lowering

全文HTML

目录

1. 解放军421医院药剂科, 广东广州 510310

2. 上海交通大学农业与生物学院, 上海 200240;上海交通大学药学院, 上海 200240

3. 上海交通大学药学院, 上海 200240

4. 第二军医大学中医系, 上海 200433

5. 第二军医大学药学院, 上海 200433